心臟超音波图市场—2026-2031年预测

预计到 2025 年，心臟超音波图市场规模将达到 23.37 亿美元，到 2031 年将达到 34.44 亿美元，复合年增长率为 6.67%。

由于心臟超音波图市场将稳定成长。这项医疗程序利用高频超音波即时显示心臟的结构和功能，在避免侵入性技术风险的同时，提供关键资讯。市场扩张的驱动因素包括人口趋势、技术创新以及基于超音波的心臟影像成像的临床优势。

推动市场成长的主要因素是全球心血管疾病盛行率的不断上升。久坐的生活方式加上全球人口老化，加重了心臟和循环系统疾病的负担，从而持续催生了对有效诊断工具的需求。这一人口结构变化尤其显着，因为老年人更容易患心臟病，这进一步增加了对便捷可靠的诊断成像技术（例如心臟超音波图）的需求。

超音波心动图相对于其他心臟诊断方法的固有优势是其市场发展的关键驱动因素。与心臟导管插入术等侵入性检查不同，后者存在併发症风险且需要长时间住院，而心臟超音波图具有非侵入性、安全且通常经济高效的优点。在心电图等初步评估之后，超音波心动图已成为心血管诊断流程中的常规检查手段，这确保了其在临床实践中持续广泛应用。

技术进步是推动市场发展的强大动力。成像技术的持续创新正在拓展心臟超音波图的效用和应用范围。包括心臟内超音波（ICE）在内的先进技术的开发和广泛应用，使得诸如电生理手术引导等更复杂的应用成为可能。这些技术进步提高了手术的精准度，并有可能减少某些手术对全身麻醉的需求，从而改善患者预后并扩大手术的应用范围。

在市场中，胸前心臟超音波（TTE）预计将占据显着的收入份额。作为最常用的心臟超音波图，TTE能够提供心臟结构和功能的全面详细资讯，指南诊断和指导治疗决策。其操作简便、即时提供资讯、非侵入性且成本相对较低等优势，使其在加护病房和常规临床环境中尤为重要，从而巩固了其主导地位。

预计北美地区将呈现显着成长，这主要得益于该地区心臟病高发、医疗基础设施高度发达且技术先进，以及对患者照护的高度重视。不断增长的老年人口尤其容易罹患心血管疾病，这进一步推动了对微创诊断程序（例如心臟超音波图）的需求。

当前竞争格局的特点是注重产品创新和策略发展。製造商正致力于开发便携式、紧凑型心电图 (ECG) 和便携性心动图设备，以满足行动医疗专业人员的需求，并支援在各种环境下进行快速诊断。关键产业趋势包括增强与电子健康记录(EMR) 和心血管资讯系统 (CVIS)的互通性，以简化工作流程。此外，各公司正积极开发穿戴式和行动监测设备，反映出市场策略正向分散式和连续性心臟监测转变。预计这一趋势将创造新的成长机会，并增强市场竞争力。

本报告的主要优势：

• 深入分析：取得以客户群、政府政策和社会经济因素、消费者偏好、垂直产业和其他细分市场为重点的深入市场洞察，涵盖主要地区和新兴地区。
• 竞争格局：了解主要企业采取的策略倡议，并了解透过正确的策略打入市场的潜力。
• 市场驱动因素与未来趋势：探索动态因素和关键市场趋势，以及它们将如何塑造未来的市场发展。
• 可执行的建议：利用洞察力为策略决策提供讯息，从而在动态环境中开拓新的业务管道和收入来源。
• 受众范围广：对新兴企业、研究机构、顾问公司、中小企业和大型企业都有益处且经济高效。

它是用来做什么的？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范及其影响、新产品开发、竞争影响

分析范围

• 历史资料（2021-2025 年）和预测资料（2026-2031 年）
• 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
• 竞争对手定位、策略和市场占有率分析
• 按业务板块和地区（国家）分類的收入成长和预测分析
• 公司概况（策略、产品、财务资讯、关键趋势等）

目录

第一章执行摘要

第二章市场概述

• 市场概览
• 市场定义
• 分析范围
• 市场区隔

第三章 商业情境

• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析
• 产业价值链分析
• 政策和法规
• 策略建议

第四章 技术展望

第五章 按类型分類的心臟超音波图市场

• 介绍
• 胸前心臟超音波
• 经食道心臟心臟超音波图
• 应力超音波心动心臟超音波图

第六章 依技术心臟超音波图市场

• 介绍
• 二维心臟超音波图
• 三维心臟超音波图
• 其他的

第七章 依最终使用者分類的心臟超音波图市场

• 介绍
• 医院
• 诊断中心
• 其他的

第八章 各地区的心臟超音波图市场

• 介绍
• 北美洲
  • 我们
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他的
• 欧洲
  • 德国
  • 法国
  • 英国
  • 西班牙
  • 其他的
• 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 以色列
  • 其他的
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 印尼
  • 泰国
  • 其他的

第九章：竞争格局与分析

• 主要企业和策略分析
• 市占率分析
• 企业合併、协议、商业合作
• 竞争对手仪錶板

第十章：公司简介

• Fujifilm Holdings Corporation
• Koninklijke Philips NV
• ULTRA ICE PLUS（TM）Ultrasound Imaging Catheter
• Canon Inc.
• ESAOTE SPA
• CHISON Medical Technologies Co., Ltd
• Samsung Healthcare（Samsung Electronics Co. Ltd）
• Siemens Healthineers（Siemens）
• GE Healthcare
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

第十一章附录

• 货币
• 先决条件
• 基准年和预测年时间表
• 相关人员的主要收益
• 分析方法
• 简称

The echocardiography market is forecasted to rise at a 6.67% CAGR, reaching USD 3.444 billion in 2031 from USD 2.337 billion in 2025.

The echocardiography market is positioned for steady growth, underpinned by its critical role as a non-invasive diagnostic modality for cardiovascular assessment. This medical procedure utilizes high-frequency ultrasound waves to generate real-time images of the heart's structure and function, providing vital information without the risks associated with invasive techniques. The market's expansion is driven by a convergence of demographic trends, technological innovation, and the clinical advantages of ultrasound-based cardiac imaging.

A primary catalyst for market growth is the escalating global prevalence of cardiovascular diseases. The increasing burden of heart and circulatory ailments, compounded by sedentary lifestyles and an aging global population, creates a sustained demand for effective diagnostic tools. This demographic shift is particularly significant as elderly populations are more susceptible to cardiac conditions, thereby amplifying the need for accessible and reliable diagnostic imaging such as echocardiography.

The intrinsic advantages of echocardiographic devices over alternative cardiac diagnostic methods represent a significant market driver. Unlike invasive procedures like cardiac catheterization, which carry risks of complications and require extended hospital stays, echocardiography is non-invasive, safer, and typically more cost-effective. Its established position in the cardiovascular diagnostic workflow, often following initial assessments like electrocardiography, ensures its continued and widespread use in clinical practice.

Technological advancement is a powerful force propelling the market forward. Continuous innovation in imaging capabilities is enhancing the utility and application of echocardiography. The development and adoption of advanced techniques, including 4D intracardiac echo (ICE), are expanding its use into complex areas such as guiding electrophysiology procedures. These technological improvements offer greater precision and can potentially reduce the need for general anesthesia in certain interventions, thereby improving patient outcomes and expanding the procedure's applicability.

Within the market, the transthoracic echocardiography (TTE) test segment is anticipated to hold a significant revenue share. As the most commonly prescribed form of echocardiography, TTE offers comprehensive details on cardiac structure and function, aiding in diagnosis and guiding treatment decisions. Its advantages-including ease of use, real-time information delivery, noninvasive nature, and relatively low cost-make it particularly valuable in intensive care units and standard clinical settings, securing its dominant position.

Geographically, North America is expected to exhibit significant growth. This is attributed to the region's high prevalence of cardiac diseases, a well-developed and technologically advanced healthcare infrastructure, and a strong emphasis on patient care. The growing elderly population in the region, which is disproportionately affected by cardiovascular problems, further fuels the demand for minimally invasive diagnostic procedures like intracardiac echocardiography.

The competitive landscape is characterized by a focus on product innovation and strategic development. Manufacturers are increasingly concentrating on creating portable, compact, and transportable ECG and echo devices to cater to mobile healthcare practitioners and enable rapid diagnosis in diverse settings. A key industry trend involves enhancing interoperability with electronic medical record (EMR) and cardiovascular information systems (CVIS) to streamline workflow. Furthermore, companies are actively developing wearable and mobile monitoring equipment, reflecting a strategic move towards decentralized and continuous cardiac monitoring, which is anticipated to unlock new growth opportunities and strengthen market competitiveness.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2021 to 2025 & forecast data from 2026 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Echocardiography Market Segmentation:

• By Type
• Transthoracic Echocardiography
• Transesophageal Echocardiography
• Stress Echocardiography
• By Technology
• 2D Echocardiography
• 3D Echocardiography
• Others
• By End-User
• Hospitals
• Diagnostic Centers
• Others
• By Geography
• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. ECHOCARDIOGRAPHY MARKET BY TYPE

• 5.1. Introduction
• 5.2. Transthoracic Echocardiography
• 5.3. Transesophageal Echocardiography
• 5.4. Stress Echocardiography

6. ECHOCARDIOGRAPHY MARKET BY TECHNOLOGY

• 6.1. Introduction
• 6.2. 2D Echocardiography
• 6.3. 3D Echocardiography
• 6.4. Others

7. ECHOCARDIOGRAPHY MARKET BY END-USER

• 7.1. Introduction
• 7.2. Hospitals
• 7.3. Diagnostic Centers
• 7.4. Others

8. ECHOCARDIOGRAPHY MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Israel
  • 8.5.4. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Fujifilm Holdings Corporation
• 10.2. Koninklijke Philips N.V.
• 10.3. ULTRA ICE PLUS(TM) Ultrasound Imaging Catheter
• 10.4. Canon Inc.
• 10.5. ESAOTE SPA
• 10.6. CHISON Medical Technologies Co., Ltd
• 10.7. Samsung Healthcare (Samsung Electronics Co. Ltd)
• 10.8. Siemens Healthineers (Siemens)
• 10.9. GE Healthcare
• 10.10. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations